Adastra Holdings Announces Completion of Sale of Subsidiaries
Adastra Holdings (OTC:XTXXF) announced on October 15, 2025 that it completed the sale of all issued and outstanding shares of three wholly owned subsidiaries for aggregate consideration of $4,000,000. The consideration comprised $495,000 for Adastra Labs via a 12% interest-bearing promissory note, $3,500,000 satisfied by the purchaser's assumption of existing mortgage debt on the Langley, BC property, and $5,000 cash for Adastra Brands.
As part of closing, the seller arranged a leaseback: 1178562 will lease 13,000 sq ft to Adastra Labs Inc. for $35,000/month, and Adastra Brands licensed trademarks to the company for an annual license fee. The company said these transactions strengthen the balance sheet, reduce debt, and allow continued operations at the existing facility while retaining brand use.
Adastra Holdings (OTC:XTXXF) ha annunciato il 15 ottobre 2025 che ha completato la vendita di tutte le azioni emesse e in circolazione di tre filiali interamente di proprietà per una controparte complessiva di $4,000,000. La contropartita è stata composta da $495,000 per Adastra Labs tramite una nota promissoria a interesse del 12%, $3,500,000 soddisfatti dall'assunzione da parte dell'acquirente del debito ipotecario esistente sulla proprietà di Langley, BC, e $5,000 in contanti per Adastra Brands.
Come parte della chiusura, il venditore ha predisposto un leaseback: 1178562 affitterà 13.000 piedi quadrati a Adastra Labs Inc. per $35,000/mese, e Adastra Brands ha concesso in licenza i marchi all'azienda per una tariffa annuale di licenza. La società ha affermato che queste transazioni rafforzano il bilancio, riducono il debito e permettono di continuare le operazioni presso l'impianto esistente mantenendo l'uso del marchio.
Adastra Holdings (OTC:XTXXF) anunció el 15 de octubre de 2025 que completó la venta de todas las acciones emitidas y en circulación de tres subsidiarias plenamente en propiedad por una contraprestación total de $4,000,000. La contraprestación consistió en $495,000 para Adastra Labs mediante una nota promissoria con interés del 12%, $3,500,000 satisfechos por la asunción por parte del comprador de la deuda hipotecaria existente sobre la propiedad de Langley, BC, y $5,000 en efectivo para Adastra Brands.
Como parte del cierre, el vendedor acordó un leaseback: 1178562 dará en alquiler 13,000 pies cuadrados a Adastra Labs Inc. por $35,000/mes, y Adastra Brands licenciaron las marcas a la empresa por una tarifa anual de licencia. La compañía dijo que estas transacciones fortalecen el balance, reducen la deuda y permiten continuar operando en las instalaciones existentes manteniendo el uso de la marca.
Adastra Holdings (OTC:XTXXF)은 2025년 10월 15일에 자회사 3곳의 발행·유통 주식 전부를 전액 소유로 매각했으며 총 대가가 $4,000,000이라고 발표했습니다. 대가는 Adastra Labs에 대해 12% 이자 부가기일이 포함된 약속어음 $495,000, Langley, BC 부동산의 기존 모기지 채무를 매수인이 인수함으로써 달성된 $3,500,000, Adastra Brands에 대해 현금 $5,000으로 구성되었습니다.
클로징의 일환으로 매도인은 리스백을 주선했습니다: 1178562가 Adastra Labs Inc.에 대해 13,000 제곱피트를 월 $35,000에 임대하고, Adastra Brands는 회사에 대한 연간 라이선스 비용으로 상표를 라이선스했습니다. 회사는 이러한 거래가 대차대조표를 강화하고 부채를 줄이며 기존 시설에서 브랜드 사용 권한을 유지하며 운영을 계속할 수 있게 한다고 밝혔습니다.
Adastra Holdings (OTC:XTXXF) a annoncé le 15 octobre 2025 avoir terminé la vente de toutes les actions émises et en circulation de trois filiales détenues en totalité pour une contrepartie globale de $4 000 000. Cette contrepartie se décomposait en $495 000 pour Adastra Labs via une note promissoire portant intérêt de 12 %, $3 500 000 satisfaits par la prise en charge par l'acheteur de la dette hypothécaire existante sur la propriété de Langley, BC, et $5 000 en espèces pour Adastra Brands.
Dans le cadre de la clôture, le vendeur a organisé une opération de leaseback: 1178562 louera 13 000 pieds carrés à Adastra Labs Inc. pour $35 000/mois, et Adastra Brands a licencié des marques à la société pour des droits annuels de licence. La société a déclaré que ces transactions renforcent le bilan, réduisent la dette et permettent de poursuivre les opérations dans l'installation existante tout en conservant l'usage de la marque.
Adastra Holdings (OTC:XTXXF) gab am 15. Oktober 2025 bekannt, dass es den Verkauf aller ausgegebenen und umlaufenden Anteile von drei vollständig im Besitz befindlichen Tochtergesellschaften für eine gesamte Gegenleistung von $4,000,000 abgeschlossen hat. Die Gegenleistung setzte sich aus $495,000 für Adastra Labs über eine zinsbringende 12%-Darlehensklausel, $3,500,000, erfüllt durch die Übernahme der bestehenden Hypothekenschulden auf die Langley, BC-Immobilie durch den Käufer, und $5,000 in bar für Adastra Brands zusammen.
Im Rahmen des Abschlusses arrangierte der Verkäufer ein Leaseback: 1178562 wird 13.000 Quadratfuß an Adastra Labs Inc. vermieten für $35,000 pro Monat, und Adastra Brands lizenziert der Firma Markenrechte gegen eine jährliche Lizenzgebühr. Das Unternehmen sagte, diese Transaktionen würden die Bilanz stärken, die Schulden reduzieren und ermöglichen, den Betrieb am bestehenden Standort fortzusetzen, während die Markenverwendung erhalten bleibt.
Adastra Holdings (OTC:XTXXF) أعلنت في 15 أكتوبر 2025 أنها أكملت بيع جميع الأسهم المصدرة والمعلنة لثلاثة فروع مملوكة بالكامل مقابل مقابل إجمالي قدره $4,000,000. comprised كالمقابل $495,000 لـ Adastra Labs عبر سند إذني بفائدة قدرها 12%، و$3,500,000 يتم الوفاء به بتحمل المشتري ديون الرهن العقاري الموجودة على عقار Langley، BC، و$5,000 نقدًا لـ Adastra Brands.
كجزء من الإغلاق، رتب البائع عقد إيجار عكسي: ستؤجر 1178562 ما مساحته 13,000 قدم مربع لـ Adastra Labs Inc. بمبلغ $35,000/شهريًا، ومرخصة Adastra Brands العلامات التجارية للشركة مقابل رسم ترخيص سنوي. قالت الشركة إن هذه المعاملات تقوِّي الميزانية وتقلل الدين وتسمح باستمرار العمليات في المنشأة الحالية مع الاحتفاظ باستخدام العلامة التجارية.
Adastra Holdings (OTC:XTXXF) 于 2025 年 10 月 15 日宣布完成对三家全资子公司已发行在外的全部股权的出售，综合对价为 $4,000,000。对价包括用于 Adastra Labs 的 $495,000，通过一份 12% 利息的本票支付；买方承担 Langley, BC 物业现有抵押债务后再以 $3,500,000 抵偿；以及 Adastra Brands 的 $5,000 美元现金。
在交割时，出售方安排了回租：1178562 将向 Adastra Labs Inc. 出租 13,000 平方英尺，月租 $35,000，并且 Adastra Brands 将商标许可给该公司，年许可费。公司表示这些交易将 加强资产负债表、减少债务，并在现有设施内维持运营，同时保留品牌使用权。
- Aggregate proceeds of $4,000,000
- Mortgage assumption valued at $3,500,000 reduces company debt
- Promissory note of $495,000 at 12% provides deferred cash
- Leaseback secures 13,000 sq ft for operations
- Continues using trademarks via licensing agreement
- Lease commitment of $35,000 per month increases cash outflow
- 12% interest on promissory note raises financing cost
Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("1178562"), and Adastra Brands Inc. ("Adastra Brands"), to 1538634 B.C. Ltd. (the "Purchaser").
The aggregate consideration for all transactions was
In connection with the closing of the transactions, 1178562 and the Company's wholly owned subsidiary, Adastra Labs Inc., entered into a lease agreement pursuant to which 1178562 agreed to lease 13,000 square feet of warehouse and office space located at the Property to Adastra Labs Inc. in consideration for
The completion of these transactions strengthens the Company's balance sheet, reduces debt, and streamlines operations. Through the related leaseback and intellectual property licensing agreements, the Company will continue to operate from its existing facility and retains the right to use its established brands and trademarks.
About Adastra Holdings Ltd.
Adastra has become one of Canada's leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are now well established with a growing distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Adastra partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market, with the ultimate aim of addressing the needs of patients. For more information, visit: www.adastraholdings.ca.
For additional information, please contact:
Jonathan Edwards, CFO
(778) 715-5011
info@adastraholdings.ca
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "expected," "anticipated," "will," or similar expressions. Forward-looking statements in this press release include but are not limited to the Company strengthening its balance sheet, reducing debt, and streamlining operations, and the Company continuing to operate from its existing facility and retaining the right to use its established brands and trademarks. These forward-looking statements are made as of the date of this press release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors include, among others, the ability to satisfy customary closing conditions and obtain any necessary regulatory approvals. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
The Canadian Securities Exchange has not reviewed this press release and does not accept responsibility for the adequacy or accuracy of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270620
FAQ
What did Adastra Holdings (XTXXF) sell on October 15, 2025?
How was the $4,000,000 consideration for XTXXF structured?
Will Adastra Holdings (XTXXF) still operate at its Langley facility after the sale?
Does Adastra Holdings (XTXXF) retain its brands and trademarks after the sale?
How do these transactions affect XTXXF's balance sheet and debt?
